Myristoylation of the Fus1 Protein Is Required for Tumor Suppression in Human Lung Cancer Cells

Cancer Research

Volumn 64, Issue 9, 2004, Pages 2969-2976

  Uno, Futoshi ^a   Sasaki, Jiichiro ^a   Nishizaki, Masahiko ^a   Carboni, Giovanni ^a   Xu, Kai ^a   Atkinson, Edward N ^a   Kondo, Masashi ^b   Minna, John D ^b   Roth, Jack A ^a   Ji, Lin ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN FUS1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; FUS1 GENE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MOUSE; MYRISTYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEIN MODIFICATION; PROTEIN SECONDARY STRUCTURE; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; MYRISTIC ACID; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUBCELLULAR FRACTIONS; UBIQUITINS;

EID: 2342472611     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3702     Document Type: Article

References (34)

1. Lerman MI, Glenn GM, Daniel L, et al. A new polymorphic probe on chromosome 3p: lambda L1B28-77 (D3S169E). Nucleic Acids Res 1990;18:205.
2. Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 2000;60:6116-33.
3. Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002;21:6915-35.
4. Ji L, Nishizaki M, Gao B, et al. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res 2002;62:2715-20.
5. 1 arrest and growth inhibition of lung cancer cells. Oncogene 2001;20:6258-62.
6. Ramesh R, Saeki T, Templeton NS, et al. Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector. Mol Ther 2001;3:337-50.
7. Fondon JW, Mele GM, Brezinschek RI, et al. Computerized polymorphic marker identification: experimental validation and a predicted human polymorphism catalog. Proc Natl Acad Sci USA 1998;95:7514-9.
8. Ji L, Fang B, Yen N, Fong K, Minna JD, Roth JA. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res 1999;59:3333-9.
9. Cai H, Wang Y, McCarthy D, et al. BACE1 is the major beta-secretase for generation of Aβ peptides by neurons. Nat Neurosci 2001;4:233-4.
10. Davies H, Lomas L, Austen BM. Profiling of amyloid β peptide variants using SELDI ProteinChip arrays. Biotechniques 1999;27:1258-61.
11. von Eggeling E, Davies H, Lomas L, et al. Tissue-specific microdissection coupled with ProteinChip array technologies: Applications in cancer research. Biotechniques 2000;29:1066-70.
12. Wistuba II, Behrens C, Virmani AK, et al. High resolution chromosome 3p allelo-typing of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 2000;60:1949-60.
13. Yaffe MB, Leparc GG, Lai J, Obata T, Volinia S, Cantley LC. A motif-based profile scanning approach for genome-wide prediction of signaling pathways. Nat Biotechnol 2001;19:348-53.
14. Feliciello A, Gottesman ME, Avvedimento EV. The biological functions of A-kinase anchor proteins. J Mol Biol 2001;308:99-114.
15. Herberg FW, Maleszka A, Eide T, Vossebein L, Tasken K. Analysis of A-kinase anchoring protein (AKAP) interaction with protein kinase A (PKA) regulatory subunits: PKA isoform specificity in AKAP binding. J Mol Biol 2000;298:329-39.
16. Maitra A, Wistuba II, Virmani AK, et al. Enrichment of epithelial cells for molecular studies. Nat Med 1999;5:459-63.
17. Baumeistar W, Walz J, Zuhl F, Seemuller E. The proteasome: paradigm of a self-compartmentalizing protease. Cell 1998;92:367-80.
18. Ames JB, Tanaka T, Stryer L, Ikura M. Portrait of a myristoyl switch protein. Curr Opin Struct Biol 1996;6:432-8.
19. Ames JB, Ishima R, Tanaka T, Gordon JI, Stryer L, Ikura M. Molecular mechanics of calcium-myristoyl switches. Nature (Lond) 1997;389:198-202.
20. Resh MD. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim Biophys Acta 1999;1451:1-16.
21. Templeton NS, Lasic DD, Frederik PM, Strey HH, Roberts DD, Pavlakis GN. Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 1997;15:647-52.
22. Bhatnagar RS, Futterer K, Farazi TA, et al. Structure of N-myristoyltransferase with bound myristoylCoA and peptide substrate analogs. Nat Struct Biol 1998;5:1091-7.
23. Kamps MP, Buss JE, Sefton BM. Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation. Proc Natl Acad Sci USA 1985;82:4625-8.
24. Manenti S, Sorokine O, Van Dorsselaer A, Taniguchi H. Demyristoylation of myristoylated alanine-rich C kinase substrate. Biochem Soc Transact 1995;23:561-4.
25. Manenti S, Malecaze F, Chap H, Darbon JM. Overexpression of the myristoylated alanine-rich C kinase substrate in human choroidal melanoma cells affects cell proliferation. Cancer Res 1998;58:1429-34.
26. Song J, Hirschman J, Gunn K, Dohlman HG. Regulation of membrane and subunit interactions by N-myristoylation of a G protein alpha subunit in yeast. J Biol Chem 1996;271:20273-83.
27. Celeste A, Petersen S, Romanienko PJ, et al. Genomic instability in mice lacking histone H2AX. Science (Wash DC) 2002;296:922-7.
28. Cook DL, Gerber AN, Tapscott SJ. Modeling stochastic gene expression: Implications for haploinsufficiency. Proc Natl Acad Sci USA 1998;95:15641-6.
29. Dworkin J. Losick R. Differential gene expression governed by chromosomal spatial asymmetry. Cell 2001;107:339-46.
30. McLaughlin MEJ. Thinking beyond the tumor cell: Nf1 haploinsufficiency in the tumor environment. Cancer Cell 2002;1:408-10.
31. Seidman JG, Seidman C. Transcription factor haploinsufficiency: when half a loaf is not enough. J Clin Investig 2002;109:451-5.
32. Veitia RA. Exploring the etiology of haploinsufficiency. Bioessays 2002;24:175-84.
33. Zhu Y, Ghosh P, Chamay P, Burns DK, Parada LF. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science (Wash DC) 2002;296:920-2.
34. Pihan GDS. Mutations and aneuploidy: co-conspirators in cancer? Cancer Cell 2003;4:89-94.